Researchers have developed EVE-Vax, a computational design tool that creates synthetic SARS-CoV-2 spike proteins mimicking future immune-evading variants. These designed proteins enable early ...

COVID-19 or SARS-CoV-2 continues to circulate globally through its impact varies by region and is influenced by factors such as vaccination rates, emerging variants, and public health measures 1.

In simple terms: a mutation is a stable change in genetic sequence that can be copied when cells or viruses replicate. Most mutations have no detectable effect, some contribute to disease, and a small ...

An electronic 96-channel pipette was one of the tools used to scale up and allow the teamto perform over 7,000 parallel experiments that uncovered more than 100 bNAb escapemutations across 15 viral ...

Hepatitis B virus (HBV) genotype C exhibits two distinct polymorphisms in its viral polymerase: rt269I and rt269L. Recently, we reported that there are distinct virological and clinical profiles ...

For COVID-19 researchers, the new year brings a strong sense of déjà vu. As in early 2020, the world is anxiously watching a virus spread in one country and trying to parse the risk for everyone else.

Scientists have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade ...

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily doses of antiretroviral drugs. In one recent clinical ...

Iowa State University researchers are using artificial intelligence to anticipate viral mutations and design vaccines for livestock diseases such as PRRS and infectious bronchitis. By identifying ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. A rare ...

Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...